About Hemab Therapeutics, Inc. (adapted from Hemab Therapeutics, Inc. prospectus):
They are a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.